Answers are grounded in this paper and cite their sources.
The intraocular lens (IOL) can be used as a slow-release drug carrier in cataract surgery to alleviate posterior capsular opacification (PCO). The following is a systematic development of an IOL using methotrexate and the solvent casting process with poly (lactic-co-glycolic acid) (PLGA) as a carrier polymer.
No takes yet. Share an insight, caveat, or question.
Bill et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: